Polarized immune responses differentially regulate cancer development.
about
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?Pattern-recognition receptors and gastric cancerChanging perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agentsExpression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changesTranscriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanomaDietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expressionEpidermal barrier defects link atopic dermatitis with altered skin cancer susceptibilityTumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicityLymphocytes in cancer development: polarization towards pro-tumor immunityThe NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses.Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airwaysSystemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose InterferonPlasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case-control study.Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.Cancer and inflammation: promise for biologic therapy.Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltrationEnhanced frequency and potential mechanism of B regulatory cells in patients with lung cancerImmune regulation of cancerProteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosisMonocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activatorThe role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells.A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases.Chronic allergic contact dermatitis promotes skin cancerWhat can ecology teach us about cancer?CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerTumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune responseA peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skinBreast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progressionConcomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer.Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis.Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.Transcription factor ATF3 links host adaptive response to breast cancer metastasis.Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.
P2860
Q26738293-EFF9DF06-EAD5-4347-9EAB-B6DA611D2389Q26991941-A0814EC0-627D-4DE4-884D-3B24DACA3E06Q28073524-A51AD39A-51F6-440E-838A-314AD6B9D45CQ28292423-E0E278F5-6217-4D08-BEEA-9D2E525057F0Q28743603-54F5DA17-B64C-4A25-A0B0-3D14EB2ED029Q29615766-EF979F97-8949-4A91-A085-0FA9636179B3Q33555117-1AE74E25-FA83-4AF2-928F-420C9AF01F20Q33698636-DDA26387-08B6-48C1-B8F4-A690D95581C2Q33712435-E8E47DE5-A55C-41A0-B2AE-DB6B3308B194Q33717170-EECF0FC2-181B-461B-A1FE-F701EEE4E379Q33809320-37078DC4-0D75-43DF-B3C3-15C2C2D5C54FQ33904496-9DA7546D-F27D-4467-B2C3-A0FAB86CC624Q34059662-DCF695CF-84D1-4041-BD90-BD143ED2ED18Q34132958-0BBCB53D-AD7C-4A15-A0EE-982891D8AC8CQ34139732-E82C0B82-05E6-42D2-B0B0-9A89CA6F7F3CQ34346730-B982AA45-67D8-47B4-BA47-4B3FD0715BEDQ34537331-7AF88CF1-E773-483B-AF91-836842DECC32Q34586327-47846E5F-8998-446C-8599-4FF6BDA93F1DQ34616787-53C66345-0BB6-4212-92AB-92B71B8CFB39Q34676770-6FD801F0-2CCE-448F-8856-D84059048007Q34982772-22B64950-A39D-49A6-91B1-27DA8D822FD6Q35009135-681435B4-4105-4DB2-A82E-7645D2621BE7Q35139996-6C83EE38-6BD7-425E-93A5-DC5405BB982FQ35182579-6708211F-860E-4DEA-A896-4160F4A11EFEQ35190645-41ACBAF9-A0B0-42EE-88AA-825F20EFD2CEQ35485418-6530F45E-ECC4-4E1C-B402-D27A39BC5772Q35974293-3E52B62D-ECF3-46EE-8438-FCDF0481CC48Q35985276-41E8038E-25B9-4BF9-BF8C-E41133570664Q36096051-9C61742A-50A6-448A-9B1C-856486430CACQ36288241-69F421E0-58A9-409A-83C6-CB0DA80B5D8CQ36339643-E1CAC967-F174-414A-9B17-F17F4921FBC6Q36345757-72A0C76D-9620-4979-80E2-5ACAFC7DE4A3Q36545058-907F5E9E-04DD-4A00-8DF9-53FA4CBCBB55Q36567697-E7C9BD4F-8D7E-4D00-AEB2-E76D02E22D76Q36605526-F1660BEB-5CF7-4B96-A3BC-5B02C607AF0BQ36729107-A31AEB49-9312-45EE-A719-BE26BA587DD8Q36737874-EB7EE764-6CCD-4817-A921-53152F21A9ABQ36863413-B72BD2CE-240E-4EB7-9A92-0B0DFCD3F4A1Q36966888-61657BB9-F26A-4EDB-806A-44289CEE1D39Q36970516-BE58B9BE-5A33-456C-8A59-1E1674A479D7
P2860
Polarized immune responses differentially regulate cancer development.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Polarized immune responses differentially regulate cancer development.
@ast
Polarized immune responses differentially regulate cancer development.
@en
type
label
Polarized immune responses differentially regulate cancer development.
@ast
Polarized immune responses differentially regulate cancer development.
@en
prefLabel
Polarized immune responses differentially regulate cancer development.
@ast
Polarized immune responses differentially regulate cancer development.
@en
P2093
P2860
P1476
Polarized immune responses differentially regulate cancer development.
@en
P2093
David G Denardo
Lisa M Coussens
Magnus Johansson
P2860
P304
P356
10.1111/J.1600-065X.2008.00600.X
P577
2008-04-01T00:00:00Z